home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Novel Breast Cancer Therapy Found

 
  April, 19 2005 10:02
your information resource in human molecular genetics
 
     
Breast cancers caused by mutations in BRCA1 and BRCA2 genes might be halted via a novel and targeted therapeutic strategy: interfering with the process of DNA repair

BRCA1 and BRCA2 are important for the repair of DNA damage by homologous recombination, a process in which the faulty section of DNA is swapped for a matching, healthy one.

Groups led by Alan Ashworth and Thomas Helleday now show Nature (14 April 2005, Vol. 434, No. 7035, pp. 917-921 & 913-917), that another enzyme involved in DNA repair, called poly(ADP-ribose) polymerase (PARP), becomes essential in cells that lack a working form of BRCA1 or BRCA2. Blocking PARP activity appears to leave breaks in DNA, which cause damage that cannot be repaired by recombination when BRCA1 or BRCA2 is absent.

The groups show that blocking PARP slows the growth of BRCA2-deficient tumours in mice. This same approach might be used to treat human breast cancer, because only the tumour cells in which BRCA1 or BRCA2 have stopped working would be killed.

CONTACT

Alan Ashworth (The Institute of Cancer Research, London, UK) Paper [1]
E-mail: alan.ashworth@icr.ac.uk

Thomas Helleday (Currently at: Stockholm University, Sweden) Paper [2]
E-mail: t.helleday@sheffield.ac.uk

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.